Suppr超能文献

非酒精性脂肪肝导致美国急诊部门肝病患者增加。

Nonalcoholic Fatty Liver is Contributing to the Increase in Cases of Liver Disease in US Emergency Departments.

机构信息

Betty and Guy Beatty Center for Integrated Research, Inova Health System.

Department of Medicine, Center For Liver Disease, Inova Fairfax Hospital, Falls Church, VA.

出版信息

J Clin Gastroenterol. 2019 Jan;53(1):58-64. doi: 10.1097/MCG.0000000000001026.

Abstract

GOALS/BACKGROUND: We aimed to assess temporal changes in the different types of liver disease (LD) cases and outcomes from emergency departments (EDs) across the United States.

STUDY

We used data from the National Inpatient Survey database from 2005 to 2011. The International Classification of Diseases, Ninth Revision (ICD-9) clinical modification codes identified hepatitis C virus (HCV), hepatitis B virus (HBV), alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), and other LDs including autoimmune hepatitis. We excluded cases without LD, nonhepatocellular carcinoma-related cancers, human immunodeficiency virus infection, or those with missing information. Logistic regression was used to estimate odds ratios with 95% confidence intervals. Controls were matched to cases without LD.

RESULTS

During the study period, 20,641,839 cases were seen in EDs. Of these, 1,080,008 cases were related to LD and were matched to controls without LD (N=19,557,585). The number of cases with LD increased from 123,873 (2005) to 188,501 (2011) (P<0.0001). Among cases with LD, diagnosis of HCV, HBV, and ALD remained stable during the study years (41.60% vs. 38.20%, 3.70% vs. 2.80%, and 41.4% vs. 38.5%, respectively), whereas NAFLD doubled [6.00% of all LD (2005) to 11.90% of all LD (2011) (P<0.0001)]. Diagnosis of LD in the ED independently predicted increased patient mortality [odds ratio, 1.20 (1.17 to 1.22)].

CONCLUSIONS

The number of LD cases presenting to EDs is increasing, and a diagnosis of LD is associated with a higher patient mortality for those admitted through the ED. There is a dramatic increase of NAFLD diagnoses in the ED.

摘要

目的/背景:我们旨在评估美国各地急诊科(ED)不同类型肝病(LD)病例和结局的时间变化。

研究

我们使用了 2005 年至 2011 年期间国家住院患者调查数据库的数据。国际疾病分类,第九修订版(ICD-9)临床修正代码确定了丙型肝炎病毒(HCV)、乙型肝炎病毒(HBV)、酒精性肝病(ALD)、非酒精性脂肪性肝病(NAFLD)和其他包括自身免疫性肝炎在内的 LD。我们排除了无 LD、非肝细胞癌相关癌症、人类免疫缺陷病毒感染或信息缺失的病例。使用逻辑回归估计 95%置信区间的优势比。对照与无 LD 的病例相匹配。

结果

在研究期间,ED 共诊治 20641839 例患者。其中,1080008 例与 LD 相关,并与无 LD 的对照(N=19557585)相匹配。LD 病例数从 2005 年的 123873 例增加到 2011 年的 188501 例(P<0.0001)。在 LD 病例中,HCV、HBV 和 ALD 的诊断在研究期间保持稳定(分别为 41.60%、3.70%和 41.4%,而 2005 年分别为 38.20%、2.80%和 38.5%),而 NAFLD 则翻了一番[2005 年所有 LD 的 6.00%(60008 例)到 2011 年所有 LD 的 11.90%(119008 例)(P<0.0001)]。ED 中 LD 的诊断独立预测患者死亡率增加[优势比,1.20(1.17 至 1.22)]。

结论

ED 中 LD 病例数量不断增加,而 ED 入院患者 LD 诊断与更高的患者死亡率相关。ED 中 NAFLD 诊断显著增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验